Immuneering Total Assets from 2010 to 2024

IMRX Stock

USD 2.10 0.01 0.47%

Immuneering Corp Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 97.7 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

102.6 M

Current Value

97.7 M

Quarterly Volatility

51 M

Credit Downgrade

Yuan Drop

Covid

Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as Net Interest Income of 3.5 M, Interest Income of 3.5 M or Depreciation And Amortization of 369.7 K, as well as many indicators such as Price To Sales Ratio of 207, Dividend Yield of 0.0 or PTB Ratio of 2.42. Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.

Check out the analysis of Immuneering Corp Correlation against competitors.

For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Latest Immuneering Corp's Total Assets Growth Pattern

Below is the plot of the Total Assets of Immuneering Corp over the last few years. Total assets refers to the total amount of Immuneering Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immuneering Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Immuneering Corp's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuneering Corp's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 102.58 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Immuneering Total Assets Regression Statistics

	Arithmetic Mean	44,585,666
	Geometric Mean	26,656,429
	Coefficient Of Variation	114.49
	Mean Deviation	41,471,095
	Median	14,098,609
	Standard Deviation	51,048,086
	Sample Variance	2605.9T
	Range	152.6M
	R-Value	0.73
	Mean Square Error	1300.8T
	R-Squared	0.54
	Significance	0
	Slope	8,360,719
	Total Sum of Squares	36482.7T

Immuneering Total Assets History

	2024	97.7 M
	2023	102.6 M
	2022	122.4 M
	2021	166.7 M
	2020	38.4 M

Other Fundumenentals of Immuneering Corp

Intangibles To Total Assets

Immuneering Corp Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Short Term Debt	Capital Surpluse	Intangible Assets	Current Deferred Revenue
Total Assets		0.98	0.96	-0.96	-0.77	0.82	-0.42	-0.33	0.98	1.0	0.95	1.0	0.95	0.84	0.92	0.48	-0.51	-0.41
Total Stockholder Equity	0.98		0.99	-0.89	-0.75	0.77	-0.53	-0.51	1.0	0.98	0.96	0.98	0.96	0.8	0.93	0.48	-0.49	-0.38
Net Tangible Assets	0.96	0.99		-0.89	-0.78	0.77	-0.56	-0.51	0.99	0.96	0.98	0.95	0.98	0.84	0.93	0.57	-0.5	-0.4
Net Debt	-0.96	-0.89	-0.89		0.84	-0.92	0.37	0.11	-0.89	-0.96	-0.92	-0.95	-0.92	-0.92	-0.92	-0.56	0.62	0.5
Retained Earnings	-0.77	-0.75	-0.78	0.84		-0.85	0.71	0.29	-0.75	-0.75	-0.89	-0.74	-0.89	-0.9	-0.9	-0.89	0.89	0.81
Accounts Payable	0.82	0.77	0.77	-0.92	-0.85		-0.47	-0.08	0.77	0.81	0.86	0.8	0.86	0.95	0.92	0.57	-0.62	-0.45
Net Receivables	-0.42	-0.53	-0.56	0.37	0.71	-0.47		0.78	-0.53	-0.39	-0.62	-0.38	-0.62	-0.47	-0.67	-0.66	0.7	0.6
Total Liab	-0.33	-0.51	-0.51	0.11	0.29	-0.08	0.78		-0.51	-0.31	-0.45	-0.31	-0.45	-0.13	-0.43	-0.26	0.22	0.16
Net Invested Capital	0.98	1.0	0.99	-0.89	-0.75	0.77	-0.53	-0.51		0.98	0.96	0.98	0.96	0.8	0.93	0.48	-0.49	-0.38
Total Current Assets	1.0	0.98	0.96	-0.96	-0.75	0.81	-0.39	-0.31	0.98		0.94	1.0	0.94	0.83	0.91	0.46	-0.5	-0.4
Capital Stock	0.95	0.96	0.98	-0.92	-0.89	0.86	-0.62	-0.45	0.96	0.94		0.93	1.0	0.92	0.97	0.68	-0.63	-0.51
Net Working Capital	1.0	0.98	0.95	-0.95	-0.74	0.8	-0.38	-0.31	0.98	1.0	0.93		0.93	0.82	0.9	0.44	-0.49	-0.39
Common Stock	0.95	0.96	0.98	-0.92	-0.89	0.86	-0.62	-0.45	0.96	0.94	1.0	0.93		0.92	0.97	0.68	-0.63	-0.51
Property Plant Equipment	0.84	0.8	0.84	-0.92	-0.9	0.95	-0.47	-0.13	0.8	0.83	0.92	0.82	0.92		0.91	0.72	-0.62	-0.49
Short Term Debt	0.92	0.93	0.93	-0.92	-0.9	0.92	-0.67	-0.43	0.93	0.91	0.97	0.9	0.97	0.91		0.63	-0.68	-0.53
Capital Surpluse	0.48	0.48	0.57	-0.56	-0.89	0.57	-0.66	-0.26	0.48	0.46	0.68	0.44	0.68	0.72	0.63		-0.84	-0.83
Intangible Assets	-0.51	-0.49	-0.5	0.62	0.89	-0.62	0.7	0.22	-0.49	-0.5	-0.63	-0.49	-0.63	-0.62	-0.68	-0.84		0.97
Current Deferred Revenue	-0.41	-0.38	-0.4	0.5	0.81	-0.45	0.6	0.16	-0.38	-0.4	-0.51	-0.39	-0.51	-0.49	-0.53	-0.83	0.97

Click cells to compare fundamentals

About Immuneering Corp Financial Statements

Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	102.6 M	97.7 M
Intangibles To Total Assets	0.07	0.05

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC